Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice

This study aimed to improve the effectiveness of the rabies vaccine to help alleviate and eliminate the rabies epidemic.

Health AI investments are off to a roaring start in 2025

Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what

January 15, 2025

Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin – Biotech Investments

EQS-News: Biotest AG / Key word(s): Study Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin 12.09.2023 /

September 13, 2023

FDA clears Verve to begin U.S. study of gene-editing treatment for high cholesterol

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its

October 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.